Tag Archives: Premarin
News came today that an appeals court has upheld a jury’s finding last year that Wyeth’s hormone-replacement drugs helped cause an Arkansas woman’s breast cancer. At stake was $27 million in actual damages, an amount that was upheld by the three-judge panel. The appeals court said “the evidence presented could allow a jury to find or infer that Wyeth wasContinue Reading
I recently attended The Scripps Conference on Natural Supplements in beautiful La Jolla, CA where I listened to a presentation on bio-identical hormone therapy in menopause by Dr. Steven Brody, a gynecologist and assistant clinical professor at UC San Diego School of Medicine. Dr. Brody’s time slot coincided with another, equally compelling presentation on “Chocolate and Tea: A Scientific OverviewContinue Reading
Melinda Beck’s “Health Journal” column in today’s Wall Street Journal focuses on “The 7 Things You Should Know About Hormones.“ She tries to clarify the debate over bio-identical hormone replacement therapy by offering 7 facts about bio-identicals, some of which are, well, debatable such as: don’t trust saliva tests, and hormones from compounding pharmacies aren’t safer than conventional HRT. IContinue Reading
If you’re curious or confused about bio-identical hormones, tune into the Oprah show today for a good explanation from Dr. Christiane Northrup, author of The Wisdom of Menopause (# 1 on Amazon’s long list of books on the topic) and more recently The Secret Pleasures of Menopause. Once you’ve made a decision to take hormone replacement therapy (HRT), you haveContinue Reading
A New York Times editorial published yesterday, “Whose Best Interest?” called upon all pharmaceutical companies to voluntarily participate in an online database of all payments made to doctors for speaking and consulting services. They also stated their support for a Senate bill, the Physician Payments Sunshine Act, which would establish a mandatory national registry of payments of all kinds toContinue Reading
An excellent Health Journal column in today’s Wall Street Journal, “Sorting Through the Choices for Menopause Hormones,” offers a “brief biology lesson” in the three kinds of estrogen to show that not all Hormone Replacement Therapy products are the same. Here’s a recap of the article by Melinda Beck:
Researchers at the University of North Carolina have concluded that the risk for cardiovascular disease posed by hormone use in menopause, seems to fade after women stop taking the synthetic hormones, estrogen and progestin. However, there may be a small, increased risk of other cancers.
Last month, I wrote about the FDA’s action restricting certain compounding pharmacists from dipsensing bio-identical hormones containing estriol – a form of estrogen. Wyeth, the biggest seller of prescription menopause hormones (Premarin and Prempro), had petitioned the FDA in April, 2006, to take this action complaining that many compounders make false claims about the drugs’ safety. The FDA says the two actions aren’tContinue Reading
I recently had an opportunity to interview Dr. Marsha Nunley, a San Francisco-based physician, about bioidentical hormone replacement therapy and her opinion about the FDA’s recent action against certain compounding pharmacies. She made several compelling points that I want to share with you on this blog.
The FDA announced that it will be “cracking down” on pharmacies that sell customized hormone mixtures prescribed by physicians to alleviate menopause symptoms. This is the latest move in an ongoing debate over the growing use of “compounded” hormone products.